新闻
2024-07-12
OKYO Pharma Announces Promising Categorical Data from OK-101 Phase 2 Trial in Dry Eye Disease
临床结果
2024-07-12
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
临床2期
2024-07-11
Zevra Announces FDA Advisory Committee Meeting to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
孤儿药快速通道申请上市突破性疗法
2024-07-11
Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren’s Disease
免疫疗法
2024-07-11
Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction
临床结果siRNA信使RNA
2024-07-11
Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy
细胞疗法临床研究免疫疗法
2024-07-11
复星医药:药友左乙拉西坦缓释片获批上市
一致性评价带量采购上市批准专利到期
2024-07-11
恩维达®补充新药申请获批
孤儿药申请上市上市批准
2024-07-11
一线治疗胃癌!复宏汉霖公布HER2双靶向疗法2期临床数据
临床结果生物类似药
2024-07-11
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
临床结果上市批准